Our team brought Okapi Sciences from a series A in 2008 to a healthy acquisition in 2014. The same team has merged Okapi Sciences’ livestock assets with innovations at Academia to form ViroVet. Currently we are approaching 20 FTE. Our company was elected as 2015 and 2017 startup of the year by Animal Pharm News. You can meet and connect with our board members, the founders and our investors by clicking below.

Board of Directors

Founders

Investors

George Gunn

Chairman

Chairman
Erwin Blomsma

CEO

CEO
Patrik Haesen

for AIF

for AIF
Laetitia Gerbe

for Seventure Partners

for Seventure Partners
Filip Goossens

for PMV

for PMV
Ludwig Goris

for CSCF

for CSCF
Ilse Sienaert

for GFF / KU Leuven

for GFF / KU Leuven
Yannick Vancoppenolle

for VIVES

for VIVES
CEO and representative of ViroVet in the board of Flanders.Bio

CEO and representative of ViroVet in the board of Flanders.Bio

Erwin Blomsma
CDO and representative of ViroVet in the board of Flanders Vaccine

CDO and representative of ViroVet in the board of Flanders Vaccine

Nesya Goris
COO

COO

Stefaan Wera
AIF

Agri Investment Fund

PMV

Biotech Fonds Vlaanderen

CSCF

Capricorn Sustainable Chemistry Fund

GFF

Gemma Frisius Fund

VIVES

Louvain Technology Fund

Seventure Partners

Seventure Partners AVF Fund